Clinical Trials Browser

Withdrawn × Carcinoma, Hepatocellular × toripalimab × Clear all

NCT03919383 2019-06-03

Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular